Oclassen Pharmaceuticals Inc., Laboratories Bergaderm deal

Oclassen received an exclusive license in North and South America to Bergaderm's 5-methoxypsoralen (5-MOP) to treat psoriasis and vitiligo, two common disfiguring skin diseases. 5-MOP is marketed in s...